NO161497C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.

Info

Publication number
NO161497C
NO161497C NO851466A NO851466A NO161497C NO 161497 C NO161497 C NO 161497C NO 851466 A NO851466 A NO 851466A NO 851466 A NO851466 A NO 851466A NO 161497 C NO161497 C NO 161497C
Authority
NO
Norway
Prior art keywords
homoerytromycin
aza
derivatives
preparation
therapeutic active
Prior art date
Application number
NO851466A
Other languages
English (en)
Norwegian (no)
Other versions
NO851466L (no
NO161497B (no
Inventor
James Robert Hauske
Arthur Adam Nagel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/600,252 external-priority patent/US4512982A/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO851466L publication Critical patent/NO851466L/no
Publication of NO161497B publication Critical patent/NO161497B/no
Publication of NO161497C publication Critical patent/NO161497C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO851466A 1984-04-13 1985-04-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. NO161497C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/600,252 US4512982A (en) 1984-04-13 1984-04-13 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US06/616,529 US4518590A (en) 1984-04-13 1984-06-04 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method

Publications (3)

Publication Number Publication Date
NO851466L NO851466L (no) 1985-10-14
NO161497B NO161497B (no) 1989-05-16
NO161497C true NO161497C (no) 1989-08-23

Family

ID=27083554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851466A NO161497C (no) 1984-04-13 1985-04-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.

Country Status (19)

Country Link
US (1) US4518590A (fr)
EP (1) EP0159856B1 (fr)
KR (1) KR860002111B1 (fr)
AU (1) AU549235B2 (fr)
CA (1) CA1234805A (fr)
DE (1) DE3565267D1 (fr)
DK (1) DK164785A (fr)
EG (1) EG17459A (fr)
ES (3) ES8607335A1 (fr)
FI (1) FI851449L (fr)
GR (1) GR850900B (fr)
HU (1) HU195668B (fr)
IE (1) IE57739B1 (fr)
IL (1) IL74865A (fr)
NO (1) NO161497C (fr)
NZ (1) NZ211769A (fr)
PH (1) PH21185A (fr)
PT (1) PT80270B (fr)
YU (3) YU62385A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US4904644A (en) * 1988-08-03 1990-02-27 Schering Corporation Antimicrobial compound isolated from Actinomadura fulva subsp indica
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
CA2062932A1 (fr) 1991-03-15 1992-09-16 Robert R. Wilkening 9-desoxo-9(z)-hydroxyiminoerythromycine a et derives ortho
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
ATE139697T1 (de) * 1991-04-09 1996-07-15 Abbott Lab Macrozyklische laktam-prokinetika
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
DE69403963T2 (de) * 1993-05-19 1997-11-20 Pfizer Zwischenprodukt für azithromycin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
FR2739620B1 (fr) * 1995-10-09 1997-12-19 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
USRE38426E1 (en) * 1995-10-09 2004-02-10 Aventis Pharma S.A. 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
WO2002088158A1 (fr) 2001-04-27 2002-11-07 Pfizer Products Inc. Procede de preparation de derives de 9-deoxo-9a-aza-9a-homoerythromycine a substitues en 4''
EP1482957A4 (fr) 2002-02-15 2006-07-19 Merckle Gmbh Conjugues antibiotiques
US20040005641A1 (en) 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CA2476423A1 (fr) 2002-02-15 2003-08-28 Sympore Gmbh Conjugues de composes biologiquement actifs, procedes de preparation et d'utilisation, et formulation et applications pharmaceutiques
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor

Also Published As

Publication number Publication date
KR860002111B1 (ko) 1986-11-26
DE3565267D1 (en) 1988-11-03
ES8705458A1 (es) 1987-05-01
KR850007435A (ko) 1985-12-04
AU4107085A (en) 1985-10-17
ES542134A0 (es) 1986-06-16
EP0159856B1 (fr) 1988-09-28
NO851466L (no) 1985-10-14
HU195668B (en) 1988-06-28
EG17459A (en) 1992-12-30
US4518590A (en) 1985-05-21
YU126887A (en) 1988-02-29
ES551503A0 (es) 1987-04-16
ES8704965A1 (es) 1987-04-16
IL74865A0 (en) 1985-07-31
FI851449A0 (fi) 1985-04-11
IL74865A (en) 1987-12-31
DK164785A (da) 1985-12-10
NO161497B (no) 1989-05-16
HUT37629A (en) 1986-01-23
PT80270A (en) 1985-05-01
IE850912L (en) 1985-10-13
YU126787A (en) 1988-02-29
GR850900B (fr) 1985-11-25
YU62385A (en) 1988-02-29
ES8607335A1 (es) 1986-06-16
FI851449L (fi) 1985-10-14
AU549235B2 (en) 1986-01-23
DK164785D0 (da) 1985-04-12
NZ211769A (en) 1987-10-30
PH21185A (en) 1987-08-12
EP0159856A3 (en) 1986-03-19
PT80270B (pt) 1987-10-20
ES551502A0 (es) 1987-05-01
CA1234805A (fr) 1988-04-05
IE57739B1 (en) 1993-03-24
EP0159856A2 (fr) 1985-10-30

Similar Documents

Publication Publication Date Title
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO162189C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO161373C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pteridin-derivater.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO158876C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees